Monopar Therapeutics Inc. (MNPR) Ownership

$23.60

north_east
$0.62 (2.7%)
Day's range
$22.5
Day's range
$24

Monopar Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MILLENNIUM MANAGEMENT LLC 08/14/2024 194,298 $145,335   1.00% 1.22%
GEODE CAPITAL MANAGEMENT, LLC 08/09/2024 60,036 $44,906   45.72% 0.38%
TWO SIGMA SECURITIES, LLC 08/14/2024 47,058 $34,357   100.00% 0.29%
VANGUARD GROUP INC 08/13/2024 45,167 $32,976   0.00% 0.28%
GERBER, LLC 07/22/2024 28,005 $20,446   0.00% 0.18%
VIRTU FINANCIAL LLC 08/09/2024 18,840 $14,000   -20.93% 0.12%
RAPPAPORT REICHES CAPITAL MANAGEMENT, LLC 07/18/2024 10,695 $7,808   0.00% 0.07%
TOWER RESEARCH CAPITAL LLC (TRC) 08/13/2024 7,922 $5,783   0.84% 0.05%
NEWEDGE ADVISORS, LLC 08/16/2024 3,000 $2,190   0.00% 0.02%
WELLS FARGO & COMPANY/MN 08/13/2024 2,500 $1,825   62.65% 0.02%
BANK OF AMERICA CORP /DE/ 08/14/2024 561 $410   12.20% 0.00%
FEDERATION DES CAISSES DESJARDINS DU QUEBEC 08/14/2024 80 $58   0.00% 0.00%
FMR LLC 08/13/2024 0 $0   -100.00% 0.00%
MORGAN STANLEY 10/17/2024 0 $0   -100.00% 0.00%
HRT FINANCIAL LP 08/12/2024 0 $0   -100.00% 0.00%
UBS GROUP AG 08/14/2024 0 $0   -100.00% 0.00%

Monopar Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 3 institutional investors and hedge funds held shares of Monopar Therapeutics Inc.. The most heavily invested institutionals were:

BANK OF AMERICA CORP /DE/: 0

American Portfolios Advisors: 0

SHINE INVESTMENT ADVISORY SERVICES INC: 10

2.62% of Monopar Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 10 shares in the last 24 months. This purchase volume represents approximately $236 in transactions.